Image de couverture de livre

Adaptive Phase 2/3 Design with Dose Optimization

Fuente: arXiv

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Chen, Cong, Huang, Mo, Zhang, Xuekui
Format:	Preprint
Publié:	2024
Sujets:	Applications
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Adjustment for Inconsistency in Adaptive Phase 2/3 Designs with Dose Optimization
par: Chen, Cong, et autres
Publié: (2025)

A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
par: Li, Yuhan, et autres
Publié: (2024)

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
par: Chen, Yuxuan, et autres
Publié: (2026)

Straightforward Phase I Dose-Finding Design for Healthy Volunteers Accounting for Surrogate Activity Biomarkers
par: Boulet, Sandrine, et autres
Publié: (2024)

The Backfill i3+3 Design for Dose-Finding Trials in Oncology
par: Liu, Jiaxin, et autres
Publié: (2023)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
par: Lee, Kyong Ju, et autres
Publié: (2025)

A Utility Score Framework for Dose Optimization Studies with Binary Efficacy-Safety Endpoints: Sample Size Determination and Bias Characterization
par: Gu, Xuemin, et autres
Publié: (2026)

The Modified Combo i3+3 Design for Novel-Novel Combination Dose-Finding Trials in Oncology
par: Liu, Jiaxin, et autres
Publié: (2024)

CUI-MET: Clinical Utility Index Dose Optimization Approach for Multiple-Dose, Multiple-Outcome Randomized Trial Designs
par: Zhang, Fanni, et autres
Publié: (2025)

Adaptive Weighting for Time-to-Event Continual Reassessment Method: Improving Safety in Phase I Dose-Finding Through Data-Driven Delay Distribution Estimation
par: Amevor, Robert, et autres
Publié: (2026)

Generalized Design of Basket Trials with P-value Combination Test
par: Zhou, Heng, et autres
Publié: (2024)

BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
par: Zhu, Di, et autres
Publié: (2026)

DEMO: Dose Exploration, Monitoring, and Optimization Using a Biological Mediator for Clinical Outcomes
par: Yang, Cheng-Han, et autres
Publié: (2024)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
par: Hall, Andrew, et autres
Publié: (2025)

Hybrid Non-informative and Informative Prior Model-assisted Designs for Mid-trial Dose Insertion
par: Yamada, Kana, et autres
Publié: (2026)

Improving Maximum Tolerated Dose Selection in Model-Assisted Designs for Phase I Trials through Bayesian Dose-Response Model
par: Wakayama, Rentaro, et autres
Publié: (2025)

Joint TITE-CRM for Dual Agent Dose Finding Studies
par: Barnett, Helen, et autres
Publié: (2025)

Covariance Fitting Interferometric Phase Linking: Modular Framework and Optimization Algorithms
par: Vu, Phan Viet Hoa, et autres
Publié: (2024)

Shape-to-Scale InSAR Adaptive Filtering and Phase Linking under Complex Elliptical Models
par: Yao, Shuyi, et autres
Publié: (2025)

Evaluating Bias Reduction Methods in Binary Emax Model for Reliable Dose-Response Estimation
par: Zhang, Jiangshan, et autres
Publié: (2025)

Two-stage Adaptive Design Cluster Randomised Trials
par: Watson, Samuel I., et autres
Publié: (2026)

Robust Emax Model Fitting: Addressing Nonignorable Missing Binary Outcome in Dose-Response Analysis
par: Zhang, Jiangshan, et autres
Publié: (2024)

HAL-Based Plug-in Estimation with Pointwise Asymptotic Normality of the Causal Dose-Response Curve
par: Shi, Junming, et autres
Publié: (2024)

Optimized Design of Three‐Phase EMI Filter for Electric Vehicle Onboard Charging System
par: Kai Zhou, et autres
Publié: (2025)

A Bayesian Adaptive Latent Mixture Model for Zero-Inflated Weighted Brain Connectome Analysis
par: Huang, Hsin-Hsiung, et autres
Publié: (2026)

Optimized Supergeo Design: A Scalable Framework for Geographic Marketing Experiments
par: Shaw, Charles
Publié: (2025)

Advancing Waterfall Plots for Cancer Treatment Response Assessment through Adjustment of Incomplete Follow-Up Time
par: Zhe, et autres
Publié: (2025)

Adaptive Online Experimental Design for Causal Discovery
par: Elahi, Muhammad Qasim, et autres
Publié: (2024)

Adaptive Designs in Fast-Track Registration Processes for Digital Health Applications
par: Kluge, Liane, et autres
Publié: (2025)

On the Impact of Monte Carlo Statistical Uncertainty on Surrogate-based Design Optimization
par: Erdem, Omer F., et autres
Publié: (2025)

Pharmacokinetic Measurements in Dose Finding Model Guided by Escalation with Overdose Control
par: Maity, Arnab Kumar, et autres
Publié: (2024)

Feasible Dose-Response Curves for Continuous Treatments Under Positivity Violations
par: Bao, Han, et autres
Publié: (2025)

Comparing methods to assess treatment effect heterogeneity in general parametric regression models
par: Chen, Yao, et autres
Publié: (2025)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
par: Komaki, Moka, et autres
Publié: (2025)

Multi-fidelity Bayesian Optimization Framework for CFD-Based Non-Premixed Burner Design
par: Lima, Patrick Souza, et autres
Publié: (2025)

Dependencies in Item-Adaptive CAT Data and Differential Item Functioning Detection: A Multilevel Framework
par: Kaptur, Dandan Chen, et autres
Publié: (2024)

Pharmacometrics-Enabled DOse OPtimization (PEDOOP) for Seamless Phase I-II Trials in Oncology
par: Yuan, Shijie, et autres
Publié: (2023)

Dose optimization design accounting for unknown patient heterogeneity in cancer clinical trials
par: Silva, Rebecca B., et autres
Publié: (2025)

Early-Phase Local-Area Model for Pandemics Using Limited Data: A SARS-CoV-2 Application
par: Shi, Jiasheng, et autres
Publié: (2022)

Beyond Grids: Multi-objective Bayesian Optimization With Adaptive Discretization
par: Nika, Andi, et autres
Publié: (2020)